ID2 and neoplasm: Implantation of Id2-kd N2a cells surprisingly resulted in tumor rejection in 60% of mice (Figs 1A and 2B) and these mice were subsequently protected against further wild-type Neuro2a tumor cell challenge (Fig 1B).